A simple HPLC method for doxorubicin in plasma and tissues of nude mice
- 1.3k Downloads
Doxorubicin is a cytotoxic anthracycline that has been used for the treatment of several malignancies. Several HPLC methods have been reported for the quantification of doxorubicin in biological samples. Tissue matrix effect and sample size requirements, however, have been remaining issues for simple and easy-to-adapt analytical methods in small animal experiments. The present study established a simple HPLC method for doxorubicin in plasma and tissues (tumor, heart, spleen, liver, gastrointestinal tract, brain, lung, and kidney) of nude mice. Our method required a small sample volume (100 μL plasma and 10 mg tissue), which made it possible to use each blank tissue for calibration curves. The limit of quantification was 25 ng/mL in plasma and 0.1 to 0.4 μg/mg in other tissues with recovery rates ranging from 52.4 to 95.2%. The linearity, accuracy and precision in all tissues, except gastrointestinal tract (GIT), were found to be acceptable in the range of 25–2000 ng/mL plasma and 0.1–4 ng/mg tissue. This method was used successfully to determine the drug concentration in plasma and tissues of human tumor xenograft-bearing nude mice given intratumoral doxorubicin in a polymeric drug delivery system designed for sustained release. In conclusion, the present method may be useful as a simple and easy-to-adapt, yet, sensitive analytical method of doxorubicin for plasma and tissue pharmacokinetic studies in small animals such as nude mice.
Key wordsDoxorubicin HPLC Plasma Tissue Nude mice Human tumor xenograft
Unable to display preview. Download preview PDF.
- Arnold, R. D., Slack, J. E., and Straubinger, R. M., Quantification of Doxorubicin and metabolites in rat plasma and small volume tissue samples by liquid chromatography/electrospray tandem mass spectroscopy. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 808, 141–152 (2004).PubMedCrossRefGoogle Scholar
- Chin, D. L., Lum, B. L., and Sikic, B. I., Rapid determination of PEGylated liposomal doxorubicin and its major metabolite in human plasma by ultraviolet-visible high-performance liquid chromatography. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 779, 259–269 (2002).PubMedCrossRefGoogle Scholar
- Gilbert, C. M., McGeary, R. P., Filippich, L. J., Norris, R.L., and Charles, B. G., Simultaneous liquid chromatographic determination of doxorubicin and its major metabolite doxorubicinol in parrot plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 826, 273–276 (2005).PubMedCrossRefGoogle Scholar
- Kummerle, A., Krueger, T., Dusmet, M., Vallet, C., Pan, Y., Ris, H. B., and Decosterd, L. A., A validated assay for measuring doxorubicin in biological fluids and tissues in an isolated lung perfusion model: matrix effect and heparin interference strongly influence doxorubicin measurements. J. Pharm. Biomed. Anal., 33, 475–494 (2003).PubMedCrossRefGoogle Scholar
- Ricciarello, R., Pichini, S., Pacifici, R., Altieri, I., Pellegrini, M., Fattorossi, A., and Zuccaro, P., Simultaneous determination of epirubicin, doxorubicin and their principal metabolites in human plasma by high-performance liquid chromatography and electrochemical detection. J. Chromatogr. B Biomed. Sci. Appl., 707, 219–225 (1998).PubMedCrossRefGoogle Scholar
- Tassin, J. P., Dubois, J., Atassi, G., and Hanocq, M., Simultaneous determination of cytotoxic (adriamycin, vincristine) and modulator of resistance (verapamil, S 9788) drugs in human cells by high-performance liquid chromatography and ultraviolet detection. J. Chromatogr. B Biomed. Sci. Appl., 691, 449–456 (1997).PubMedCrossRefGoogle Scholar
- Veronese, F. M., Schiavon, O., Pasut, G., Mendichi, R., Andersson, L., Tsirk, A., Ford, J., Wu, G., Kneller, S., Davies, J., and Duncan, R., PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity. Bioconjug. Chem., 16, 775–784 (2005).PubMedCrossRefGoogle Scholar